{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:15:19Z","timestamp":1777518919299,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.vaccine.2007.06.017","type":"journal-article","created":{"date-parts":[[2007,6,30]],"date-time":"2007-06-30T11:13:01Z","timestamp":1183201981000},"page":"6334-6340","source":"Crossref","is-referenced-by-count":26,"title":["Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Mary C.","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taff","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale L.","family":"Barnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Burt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George H.","family":"Lowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.vaccine.2007.06.017_bib1","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.vaccine.2007.06.017_bib2","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N Engl J Med"},{"issue":"9366","key":"10.1016\/j.vaccine.2007.06.017_bib3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"issue":"5624","key":"10.1016\/j.vaccine.2007.06.017_bib4","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"issue":"5624","key":"10.1016\/j.vaccine.2007.06.017_bib5","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.1085953","article-title":"The genome sequence of the SARS-associated coronavirus","volume":"300","author":"Marra","year":"2003","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.vaccine.2007.06.017_bib6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/15353702-0322807-13","article-title":"The complete genome sequence of severe acute respiratory syndrome coronavirus strain HKU-39849 (HK-39)","volume":"228","author":"Zeng","year":"2003","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.vaccine.2007.06.017_bib7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.vaccine.2005.08.055","article-title":"A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralizing and protective antibody responses","volume":"24","author":"Spruth","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.06.017_bib8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.vaccine.2004.07.031","article-title":"Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice","volume":"23","author":"Qu","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.06.017_bib9","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3201\/1107.050219","article-title":"SARS vaccine development","volume":"11","author":"Jiang","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.06.017_bib10","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1016\/j.vaccine.2006.01.059","article-title":"A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice","volume":"24","author":"Zhou","year":"2006","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.vaccine.2007.06.017_bib11","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1016\/j.vaccine.2005.05.023","article-title":"SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus","volume":"23","author":"Woo","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.06.017_bib12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.vaccine.2007.06.017_bib13","series-title":"New generation vaccines","first-page":"271","article-title":"Proteosome\u2122 technology for vaccines and adjuvants","author":"Lowell","year":"2004"},{"issue":"10","key":"10.1016\/j.vaccine.2007.06.017_bib14","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.vaccine.2005.09.052","article-title":"Intranasal Protollin\/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection","volume":"24","author":"Jones","year":"2006","journal-title":"Vaccine"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2007.06.017_bib15","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/j.vaccine.2004.03.035","article-title":"Protollin: a novel adjuvant for intranasal vaccines","volume":"22","author":"Jones","year":"2004","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2007.06.017_bib16","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/IAI.63.6.2382-2386.1995","article-title":"Intranasal or intragastric immunization with proteosome\u2013Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection","volume":"63","author":"Mallett","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.06.017_bib17","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/IAI.69.7.4545-4553.2001","article-title":"Safety and immunogenicity of a proteosome\u2013Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults","volume":"69","author":"Fries","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.06.017_bib18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0264-410X(01)00268-7","article-title":"Nasal immunization with subunit proteosome influenza vaccines induce serum HAI, mucosal IgA and protection against Influenza challenge","volume":"20","author":"Plante","year":"2001","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2007.06.017_bib19","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1128\/JVI.79.9.5833-5838.2005","article-title":"Aged BALB\/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans","volume":"79","author":"Roberts","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.06.017_bib20","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1016\/j.vaccine.2005.04.011","article-title":"Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines","volume":"23","author":"Zakhartchouk","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.017_bib21","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hygiene"},{"issue":"5","key":"10.1016\/j.vaccine.2007.06.017_bib22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.smim.2005.05.005","article-title":"Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans","volume":"17","author":"Frasca","year":"2005","journal-title":"Semin Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07006950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07006950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T21:45:27Z","timestamp":1587678327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07006950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":22,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0264410X07006950"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.06.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}